Many varieties of Narcissus (Amaryllidaceae) are planted on a large scale for ornamental purposes and at the same time they represent a rich reservoir of potential small chemical molecules that display several medicinal properties. Of the Amaryllidaceae alkaloids, considerable attention has been given to galanthamine, which possesses acetylcholinesterase inhibitory activity. Recent investigation has shown the pharmaceutical potential of other Amaryllidaceae alkaloids, such as lycorine, haemanthamine, and pancratistatine, primarily as anticancer drugs. In the current study, 40 Narcissus taxa were evaluated for their alkaloid profile by GC-MS. The aim of this work was to find the most suitable Narcissus varieties for a reliable source of galanthamine, lycorine, and haemanthamine for commercial production. Based on their mass spectra, 97 typical Amaryllidaceae alkaloids were detected of which 49 were identified. The highest concentrations of pharmaceutically-interesting Amaryllidaceae alkaloids were identified in the ornamental taxa N. cv Sundisc (galanthamine), N. cv. Jenny (lycorine), and N. cv. Sealing (haemanthamine). All alkaloidal extracts were also screened for their acetylcholinesterase and butyrylcholinesterase inhibitory activities.
Amaryllidaceae species contain a specific type of secondary metabolites known as Amaryllidaceae alkaloids. Modern research has shown that these compounds represent a rich reservoir of small chemical molecules, which are of great interest due to their wide range of biological properties, including antiviral, antimalarial, anticancer and anticholinesterase activities [1] [2] [3] .
Narcissus, the most common genus of the Amaryllidaceae family, comprises approximately 80-100 wild species, and is mainly distributed in South-Western Europe and North Africa, with some populations in the Balkans, Italy and France. Most Narcissus species can hybridize, and hybridization has become very popular with a large number of cultivars having been developed for ornamental purposes, with over 27,000 named Narcissus cultivars now registered in the International Daffodil Register [4] . The Amaryllidaceous cultivars have advantages for commercial alkaloid production since they are available in large quantities. Only a few studies have been published on the complete alkaloid profile of ornamental Narcissus cultivars [5] . So far, more than 100 alkaloids of various structural types have been isolated from this genus, and the found compounds possess a wide range of pharmacological properties such as antitumor, antiviral, antimalarial and acetylcholinesterase inhibitory activity [6] [7] . The most important Amaryllidaceae alkaloid is galanthamine, which is a marketed drug for Alzheimer´s disease therapy. There are several studies dealing with the content of galanthamine in ornamental amaryllidaceous plants. For example, its content was determined by GC-MS in the leaves and bulbs of 105 ornamental daffodils [8] and by HPLC in the bulbs of 20 Narcissus cultivars [9] , but there are only a few studies dealing with the content of other interesting Amaryllidaceae alkaloids, such as lycorine, haemanthamine ( Fig. 1) and pancratistatine. Lycorine, the most characteristic and common Amaryllidaceae alkaloid, is reported to be a powerful inhibitor of ascorbic acid biosynthesis, an inhibitor of galactono-γ-lactone dehydrogenase, and an inhibitor of cell growth, cell division and organogenesis in higher plants, algae, and yeasts [3] . The antitumor activity of lycorine in animals has been demonstrated by the inhibition of in vivo and in vitro growth of diverse tumor cells, including HeLa, P-388, 3T3, S-180, KB, Molt-4, BCA-1, HT-1080, MEL-2, and KB-V1 [10] . A further interesting anticancer agent from Amaryllidaceae plants is the β-crinane-type alkaloid haemanthamine, which displays significant in vitro cytotoxic activity against several different types of cancer cell lines including MOLT-4, HepG2, HeLa, MCF7, CEM, K562, A549, Caco-2, HT-29, A2780, SW1573, T47-D [1, 11, 12] . Both mentioned compounds have promise for the development of new anticancer drugs.
To our knowledge, no studies have been carried out until now on the haemanthamine, lycorine and tazettine contents of a large collection of Narcissus cultivars. GC-MS was found to be a rapid, specific and robust methodology for analysis of Amaryllidaceae alkaloids in plant extracts, requiring very little plant material and no derivatization step [8] . In the current study, 40 Narcissus taxa were evaluated for their alkaloid profile by GC-MS. Our aim was to find the most suitable Narcissus varieties for a reliable source of galanthamine and further pharmaceutically interesting Amaryllidaceae alkaloids such as lycorine, haemanthamine and tazettine for commercial production. All alkaloidal extracts have also been evaluated for their acetylcholinesterase and butyrylcholinesterase inhibitory activity.
In the bulb extracts of the studied 38 ornamental varieties and two botanical species of Narcissus, 97 compounds with typical mass spectra of Amaryllidaceae alkaloids were detected. Forty-nine of them were identified based on their mass spectra, retention times and retention indexes and belong to the crinine, galanthamine, homolycorine, lycorine, and tazettine structural type of Amaryllidaceae alkaloids. The relative proportion of each alkaloid was determined as a percentage of the total ion current (TIC). The peak areas reflect the ability of each compound to be ionized and thus the data given in Table 1 are semiquantitative. Nevertheless, they can be used for comparison between samples.
The HuAChE and HuBuChE inhibitory activities of the studied varieties and species were determined by the method employed by Ellman [13] . The results (IC 50 ) are summarized in Table 1 . It is reported that, among the plants of the family Amaryllidaceae, AChE inhibition is associated mainly with galanthamine and lycorine type alkaloids [14] . The combination of biological assay and analysis is frequently used for the selection of suitable plant species for isolation of biological active compounds.
The production cost of a natural compound is determined by the quality of the plant raw materials, namely its content and its percentage in the extract mixture. These phytochemical characteristics of the plant sources influence the efficiency of extraction technology and therefore the production costs. The main commercial source of galanthamine is Narcissus pseudonarcissus cv. Carlton due to its bulb size (4-5 cm in diameter) and high galanthamine content. Kreh et al. [15] reported 58% of galanthamine in a bulb alkaloid mixture from N. pseudonarcissus cv. Carlton based on GC-MS study. These authors also reported a further 23 alkaloids of various structural types (galanthamine, lycorine, homolycorine, haemanthamine) in the alkaloidal extract ot this cultivar [15] . All these alkaloids must be separated from galanthamine during its isolation process. In our study we found two varieties with a higher content of galanthamine compared with Narcissus cv. Carlton. The highest galanthamine content was identified in Narcissus cv. Sundisc (69% of TIC) and Narcissus cv. Waterperry (67% of TIC). Both alkaloidal extracts also demonstrated interesting HuAChE inhibition activity and the extract of Narcissus cv. Sundisc showed, in addition, interesting HuBuChE inhibition activity (Table 1 ).
In the case of lycorine, the most promising ornamental cultivars for its isolation are Narcissus cv. Jenny (90% of TIC), Narcissus cv. Hawera (90% of TIC) and N. canaliculatus (80% of TIC). In the alkaloidal extract of Narcissus cv. Jenny, only two alkaloids were identified, lycorine and tazettine. The polarity of these compounds is very different, and they can be easily separated from each other by common chromatographic methods. Tazettine, although its biological activity is low, is also an interesting Amaryllidaceae alkaloid, since it can be chemically transformed into its in-plant labile precursor pretazettine via 3-epitazettadiol [16] . Pretazettine displays cytotoxicity against fibroblastic LMTK cell lines, inhibits cell growth of HeLa cells and is therapeutically effective against advanced Rauscher leukemia, Ehrlich ascites carcinoma, spontaneous AKR lymphoblastic leukemia and Lewis lung carcinoma. It is also one of the most active Amaryllidaceae alkaloids against MOLT-4 acute lymphoblastic leukemia [17, 18] , but its content in plant material is very low, due its instability. The highest content of tazettine has been determined in Narcissus cv. Abba (62% of TIC), Narcissus cv. Sweetness (64% of TIC) and Narcissus cv. Yazz (42% of TIC).
A further interesting anticancer Amaryllidaceae agent, haemanthamine, has been identified in high concentrations in the following Narcissus varieties: cv. Sealing (43% of TIC), cv. Bridal Crown (36% of TIC) and cv. Dutch Master (32% of TIC), and belongs to the most abundant Amaryllidaceae alkaloids. In our previous report on the GC-MS fingerprint of the alkaloidal extracts of eight Narcissus species and varieties the highest concentration of haemanthamine was identified in Narcissus cv. Midget (51% of TIC), and Narcissus cv. Little Gem (50% of TIC) [5] .
It can be concluded, that ornamental taxa of daffodils are an interesting and rich source of Amaryllidaceae alkaloids. The content of the main Amaryllidaceae alkaloids galanthamine, lycorine, tazettine and haemanthamine in daffodils can vary remarkably among different varieties. 
Experimental

Extraction and isolation of alkaloids:
Fresh bulbs (3 x 15 g) were extracted 3 times with EtOH (50 mL) at room temperature for 24 h. The solvent was evaporated under reduced pressure and the residue dissolved in 10 mL 2% HCl. After removal of neutral compounds with diethyl ether (3 x 15 mL), the extract was basified with 25% ammonia solution and the alkaloids extracted with EtOAc (3 x 15 mL). The organic solvent was evaporated and 10 mg of each alkaloid extract was used for acetylcholinesterase Natural Product Communications Vol. 13 (4) 2018 421 and butyrylcholinesterase assay. The rest of the dry alkaloid fraction was dissolved in MeOH to a final concentration of 1 mg/mL for further analysis.
GC/MS analysis: GC/MS analysis was performed on an Agilent 890A GC 5975 inert MSD operating in EI mode at 70 eV (Agilent Technologies, Santa Clara, CA, USA). The separation was carried out on a DP-5 MS column (30 m × 0.25 mm × 0.25 μm, Agilent Technologies Santa Clara, CA, USA). The temperature program was from 100-150°C at 15°C/min, 1 min hold at 180°C and then180°C-300°C at 5°C/min and 35 min hold at 300°C. The injector temperature was 280°C. The flow rate of carrier gas (helium) was 0.8 mL/min. The detection range was m/z 35-600, and the detector temperature 200°C. An injection of 1 μL of alkaloid solution (1 mg/mL) was introduced in split mode (split ration 1:10). The individual alkaloids were identified based on comparison of their MS with those in the NIST library, with reported spectra in the literature, and finally with spectra of reference compounds isolated earlier in our laboratory. The confirmation of molecular weight was accomplished by a GCMS-QP2010 plus system with chemical ionization (Shimadzu, Japan). Isobutane (3.5; Linde Gas a.s. -Linde Technoplyn a.s., Czech Republic) was used as a reagent gas. The separation was carried out on a HP-5MS UI column (30 m ×0.25 mm × 0.25 μm, Agilent Technologies Santa Clara, CA, USA) and the temperature gradient described above was used. The injector temperature was maintained at 280°C. The carrier gas (helium) flow rate was set at 0.8 mL/min. An injection of 1 μL of alkaloid solution (1 mg/mL) was introduced in split mode (split 1:3) on the column. The samples were monitored in the full scan m/z 70-550. The detector temperature was kept at 200°C.
Acetylcholinesterase and butyrylcholinesterase assay:
The same procedure was used as in our previous report [19] .
Supplementary data: Supplementary data (complete GC/MS analysis and identification of Narcissus alkaloidal extracts; GC/MS chromatograms of selected Narcissus varieties) for this article can be found in the online version.
